Globe Life vs Unum: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Globe Life Inc (GL)

Q3 202613 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

July 202613 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

Latest13 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

Unum Group (UNM)

Q3 202611 Jul – 8 Oct 2026

▲3▼1

Unum cuts long-term care risk, returns cash, and beats on Q2 profit

Long-term care risk cut by $3.8B reinsurance deal Unum shifted $3.8 billion of long-term care reserves to Fortitude Re, cutting total exposure 40% since early last year. This frees capital and reduces the risk that old long-term care policies surprise the company with losses, which supports the stock.
The reinsurance deal is the biggest new event and directly lowers UNM's risk profile.
Analysts raise price targets after reinsurance deal Jefferies, Barclays and Evercore all lifted their UNM price targets, and one analyst said the deal makes Unum a stronger takeover candidate. Higher targets can pull more buyers in, though the stock dipped on the announcement day, showing some investors wanted more.
Analyst target hikes are a direct new reaction to the reinsurance deal and affect investor expectations.
Q2 profit beat and new $1B buyback Unum's second-quarter earnings per share rose to $2.16 and beat estimates, helped by strong Colonial Life results. The board then authorized a new $1 billion stock buyback, which shrinks the number of shares and returns cash to owners, both supporting the price.
The earnings beat and buyback are fresh, concrete positives that directly affect UNM's value.
One report shows revenue down 12.3% A later industry roundup reported Unum's quarterly revenue at $2.96 billion, down 12.3% and below expectations. This conflicts with the earlier upbeat earnings report and is a reminder that revenue can be uneven, which could weigh on the stock if the weakness continues.
This is the main counterweight in the period and warns readers not to see only good news.

August 202611 Jul – 8 Oct 2026

▲3▼1

Unum cuts long-term care risk, returns cash, and beats on Q2 profit

Long-term care risk cut by $3.8B reinsurance deal Unum shifted $3.8 billion of long-term care reserves to Fortitude Re, cutting total exposure 40% since early last year. This frees capital and reduces the risk that old long-term care policies surprise the company with losses, which supports the stock.
The reinsurance deal is the biggest new event and directly lowers UNM's risk profile.
Analysts raise price targets after reinsurance deal Jefferies, Barclays and Evercore all lifted their UNM price targets, and one analyst said the deal makes Unum a stronger takeover candidate. Higher targets can pull more buyers in, though the stock dipped on the announcement day, showing some investors wanted more.
Analyst target hikes are a direct new reaction to the reinsurance deal and affect investor expectations.
Q2 profit beat and new $1B buyback Unum's second-quarter earnings per share rose to $2.16 and beat estimates, helped by strong Colonial Life results. The board then authorized a new $1 billion stock buyback, which shrinks the number of shares and returns cash to owners, both supporting the price.
The earnings beat and buyback are fresh, concrete positives that directly affect UNM's value.
One report shows revenue down 12.3% A later industry roundup reported Unum's quarterly revenue at $2.96 billion, down 12.3% and below expectations. This conflicts with the earlier upbeat earnings report and is a reminder that revenue can be uneven, which could weigh on the stock if the weakness continues.
This is the main counterweight in the period and warns readers not to see only good news.

Latest11 Jul – 8 Oct 2026

▲3▼1

Unum cuts long-term care risk, returns cash, and beats on Q2 profit

Long-term care risk cut by $3.8B reinsurance deal Unum shifted $3.8 billion of long-term care reserves to Fortitude Re, cutting total exposure 40% since early last year. This frees capital and reduces the risk that old long-term care policies surprise the company with losses, which supports the stock.
The reinsurance deal is the biggest new event and directly lowers UNM's risk profile.
Analysts raise price targets after reinsurance deal Jefferies, Barclays and Evercore all lifted their UNM price targets, and one analyst said the deal makes Unum a stronger takeover candidate. Higher targets can pull more buyers in, though the stock dipped on the announcement day, showing some investors wanted more.
Analyst target hikes are a direct new reaction to the reinsurance deal and affect investor expectations.
Q2 profit beat and new $1B buyback Unum's second-quarter earnings per share rose to $2.16 and beat estimates, helped by strong Colonial Life results. The board then authorized a new $1 billion stock buyback, which shrinks the number of shares and returns cash to owners, both supporting the price.
The earnings beat and buyback are fresh, concrete positives that directly affect UNM's value.
One report shows revenue down 12.3% A later industry roundup reported Unum's quarterly revenue at $2.96 billion, down 12.3% and below expectations. This conflicts with the earlier upbeat earnings report and is a reminder that revenue can be uneven, which could weigh on the stock if the weakness continues.
This is the main counterweight in the period and warns readers not to see only good news.